Your browser doesn't support javascript.
loading
Dosimetric impact of rectum and bladder anatomy and intrafractional prostate motion on hypofractionated prostate radiation therapy.
Roch, M; Zapatero, A; Castro, P; Hernández, D; Chevalier, M; García-Vicente, F.
Affiliation
  • Roch M; Department of Medical Physics, Hospital La Princesa, Health Research Institute IIS-IP, Diego de León 62, 28006, Madrid, Spain. maria.roch@salud.madrid.org.
  • Zapatero A; Department of Radiation Oncology, Hospital La Princesa, IIS-IP, Madrid, Spain.
  • Castro P; Department of Medical Physics, Hospital La Princesa, Health Research Institute IIS-IP, Diego de León 62, 28006, Madrid, Spain.
  • Hernández D; Department of Medical Physics, Hospital La Princesa, Health Research Institute IIS-IP, Diego de León 62, 28006, Madrid, Spain.
  • Chevalier M; Medical Physics Group, Radiology Department, Complutense University of Madrid, Madrid, Spain.
  • García-Vicente F; Department of Medical Physics, Hospital Ramón Y Cajal, Madrid, Spain.
Clin Transl Oncol ; 23(11): 2293-2301, 2021 Nov.
Article in En | MEDLINE | ID: mdl-33913091
OBJECTIVE: The objective of this study was to evaluate the dosimetric impact on hypofractionated prostate radiation therapy of two geometric uncertainty sources: rectum and bladder filling and intrafractional prostate motion. MATERIALS AND METHODS: This prospective study included 544 images (375 pre-treatment cone-beam CT [CBCT] and 169 post-treatment CBCT) from 15 prostate adenocarcinoma patients. We recalculated the dose on each pre-treatment CBCT once the positioning errors were corrected. We also recalculated two dose distributions on each post-treatment CBCT, either using or not intrafractional motion correction. A correlation analysis was performed between CBCT-based dose and rectum and bladder filling as well as intrafraction prostate displacements. RESULTS: No significant differences were found between administered and planned rectal doses. However, we observed an increase in bladder dose due to a lower bladder filling in 66% of treatment fractions. These differences were reduced at the end of the fraction since the lower bladder volume was compensated by the filling during the treatment session. A statistically significant reduction in target volume coverage was observed in 27% of treatment sessions and was correlated with intrafractional prostate motion in sagittal plane > 4 mm. CONCLUSIONS: A better control of bladder filling is recommended to minimize the number of fractions in which the bladder volume is lower than planned. Fiducial mark tracking with a displacement threshold of 5 mm in any direction is recommended to ensure that the prescribed dose criteria are met.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Rectum / Urinary Bladder / Adenocarcinoma / Organ Motion Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Clin Transl Oncol Year: 2021 Document type: Article Affiliation country: Spain Country of publication: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Rectum / Urinary Bladder / Adenocarcinoma / Organ Motion Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Clin Transl Oncol Year: 2021 Document type: Article Affiliation country: Spain Country of publication: Italy